ROCK1, a novel target of miR-145, promotes glioma cell invasion

Wan,Xin; Cheng,Quan; Peng,Renjun; Ma,Zhiming; Chen,Zigui; Cao,Yiqiang; Jiang,Bing

doi:10.3892/mmr.2014.1982

ROCK1, a novel target of miR-145, promotes glioma cell invasion

Authors:
- Xin Wan
- Quan Cheng
- Renjun Peng
- Zhiming Ma
- Zigui Chen
- Yiqiang Cao
- Bing Jiang
View Affiliations

Affiliations: Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: February 25, 2014 https://doi.org/10.3892/mmr.2014.1982
Pages: 1877-1882

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant glioma is the most common type of cancer in the central nervous system, with highly invasive characteristics. The Rho-associated protein kinase (ROCK1) has been found to act as key regulator of actin cytoskeleton reorganization, a process closely associated with cancer cell invasion. microRNA-145 (miRNA-145) has been recently shown to act as a suppressor in several types of tumor, including glioma. However, the exact regulatory mechanism by which miR-145 inhibits glioma still remains to be uncovered. In this study, we report that the miR-145 level was significantly reduced in glioma tissues and in the human glioma cell lines U87 and U251, as compared to matched adjacent and normal brain tissues. We then identified the ROCK1 gene as a novel target of miR-145. The expression of ROCK1 was markedly upregulated in glioma tissues, as well as in U87 and U251 cells. Moreover, miR-145 significantly inhibited ROCK1 protein expression in U87 cells. We further show that miR-145 transfection considerably reduced the invasive ability of U87 cells, and was accompanied by the downregulation of matrix metalloproteinase 2 and 9, an effect which could be attenuated by overexpression of ROCK1. In conclusion, the present study suggests that miR-145 can inhibit U87 glioma cell invasion, at least partially via downregulation of the RhoA/ROCK1 pathway. In conclusion, this is the first study to report that ROCK1, as a novel target of miR-145, acts as a positive regulator of glioma cell invasion. Therefore, ROCK1 may constitute a promising target for glioma treatment.

View Figures

View References

1	Wang Y and Jiang T: Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
2	Nakada M, Kita D, Teng L, et al: Receptor tyrosine kinases: principles and functions in glioma invasion. Adv Exp Med Biol. 986:143–170. 2013. View Article : Google Scholar : PubMed/NCBI
3	Kwiatkowska A and Symons M: Signaling determinants of glioma cell invasion. Adv Exp Med Biol. 986:121–141. 2013. View Article : Google Scholar : PubMed/NCBI
4	Nagadia R, Pandit P, Coman WB, Cooper-White J and Punyadeera C: miRNAs in head and neck cancer revisited. Cell Oncol (Dordr). 36:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
5	Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477. 2013. View Article : Google Scholar : PubMed/NCBI
6	Wang Q, Li P, Li A, et al: Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res. 31:972012. View Article : Google Scholar : PubMed/NCBI
7	Asadi-Moghaddam K, Chiocca EA and Lawler SE: Potential role of miRNAs and their inhibitors in glioma treatment. Expert Rev Anticancer Ther. 10:1753–1762. 2010. View Article : Google Scholar : PubMed/NCBI
8	Rani SB, Rathod SS, Karthik S, Kaur N, Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro Oncol. 15:1302–1316. 2013. View Article : Google Scholar : PubMed/NCBI
9	Lu Y, Chopp M, Zheng X, Katakowski M, Buller B and Jiang F: MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep. 29:67–72. 2013.PubMed/NCBI
10	Lee SJ, Kim SJ, Seo HH, et al: Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett. 320:72–80. 2012. View Article : Google Scholar : PubMed/NCBI
11	Speranza MC, Frattini V, Pisati F, et al: NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget. 3:723–734. 2012.PubMed/NCBI
12	Chen RH, Wang WJ and Kuo JC: The tumor suppressor DAP-kinase links cell adhesion and cytoskeleton reorganization to cell death regulation. J Biomed Sci. 13:193–199. 2006. View Article : Google Scholar : PubMed/NCBI
13	Becart S and Altman A: SWAP-70-like adapter of T cells: a novel Lck-regulated guanine nucleotide exchange factor coordinating actin cytoskeleton reorganization and Ca²⁺ signaling in T cells. Immunol Rev. 232:319–333. 2009. View Article : Google Scholar
14	Hall A: Rho family GTPases. Biochem Soc Trans. 40:1378–1382. 2012. View Article : Google Scholar
15	Schofield AV and Bernard O: Rho-associated coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem Mol Biol. 48:301–316. 2013. View Article : Google Scholar : PubMed/NCBI
16	Zhou X, Wei M and Wang W: MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013. View Article : Google Scholar : PubMed/NCBI
17	Bu Q, Tang HM, Tan J, Hu X and Wang DW: Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma. Zhonghua Zhong Liu Za Zhi. 33:202–206. 2011.(In Chinese).
18	Majid S, Dar AA, Saini S, et al: MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One. 7:e467432012. View Article : Google Scholar : PubMed/NCBI
19	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
20	Oellers P, Schroer U, Senner V, Paulus W and Thanos S: ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons. Glia. 57:499–509. 2009. View Article : Google Scholar : PubMed/NCBI
21	Inaba N, Ishizawa S, Kimura M, et al: Effect of inhibition of the ROCK isoform on RT2 malignant glioma cells. Anticancer Res. 30:3509–3514. 2010.PubMed/NCBI
22	Hadler-Olsen E, Winberg JO and Uhlin-Hansen L: Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
23	Villadsen SB, Bramsen JB, Ostenfeld MS, et al: The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer. 106:366–374. 2012. View Article : Google Scholar : PubMed/NCBI
24	Chiyomaru T, Tatarano S, Kawakami K, et al: SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate. 71:1559–1567. 2011.PubMed/NCBI
25	Zhang J, Guo H, Zhang H, et al: Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer. 117:86–95. 2011. View Article : Google Scholar : PubMed/NCBI
26	Lee HK, Bier A, Cazacu S, et al: MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
27	Morgan-Fisher M, Wewer UM and Yoneda A: Regulation of ROCK activity in cancer. J Histochem Cytochem. 61:185–198. 2013. View Article : Google Scholar
28	Wen S, Shang Z, Zhu S, Chang C and Niu Y: Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells. Prostate. 73:1306–1315. 2013. View Article : Google Scholar : PubMed/NCBI
29	Wang J, Sun L, Yang M, et al: DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer. J Histochem Cytochem. 61:510–521. 2013. View Article : Google Scholar : PubMed/NCBI
30	Tang AT, Campbell WB and Nithipatikom K: ROCK1 feedback regulation of the upstream small GTPase RhoA. Cell Signal. 24:1375–1380. 2012. View Article : Google Scholar : PubMed/NCBI
31	Imamura F, Mukai M, Ayaki M and Akedo H: Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn J Cancer Res. 91:811–816. 2000. View Article : Google Scholar : PubMed/NCBI